Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Secure Trust Bank interim profits jump as customer deposits hit record

(Sharecast News) - Secure Trust Bank posted a jump in interim profit on Thursday as customer deposits hit a record high. In the six months to 30 June, adjusted pre-tax profit rose 36.3% to £23.3m, while statutory pre-tax profit increased 30.4% to £22.3m.

Customer deposits pushed up 8.2% to a record £3.5bn and net lending balances rose 6.1% to £3.8bn.

The net interest margin improved to 5.4% from 5.3% thanks to lower cost of funds in the first half of the year and improved margins in Retail Finance.

Adjusted return on average equity ticked up to 9.6% from 7.3% at the end of June 2024.

Chief executive David McCreadie said: "We are on track to deliver £8 million of annualised cost savings by the end of 2025. We recently announced a strategic pivot away from Vehicle Finance which will enable further allocation of capital to our higher-performing specialist lending businesses. This decision, alongside a strategic refresh which will be detailed at a capital markets event in Q4 2025, will position the group to deliver sustainable attractive returns.

"As previously announced, I will be retiring as the group's CEO. During my tenure, we have delivered a radical transformation of the group to position it for future growth. I wish my successor, Ian Corfield, every success in the role."

At 0920 BST, the shares were up 6.2% at 1,167.99p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.